Short Interest in Sysmex Corporation ADR (OTCMKTS:SSMXY) Drops By 67.6%

Key Points

• Short interest in Sysmex Corporation ADR has declined by 67.6%, with totals dropping from 7,400 shares at the end of July to 2,400 shares by mid-August.
• Sysmex reported a quarterly EPS of $0.05, falling short of analysts' estimates of $0.12, and its revenue of $717.09 million also missed expectations.
• Zacks Research upgraded Sysmex from a "strong sell" to a "hold" rating, with the company currently holding an average rating of "Hold" from analysts.

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) was the recipient of a significant decline in short interest in the month of August. As of August 15th, there was short interest totaling 2,400 shares, adeclineof67.6% from the July 31st total of 7,400 shares. Based on an average daily trading volume, of 161,400 shares, the short-interest ratio is presently 0.0 days. Based on an average daily trading volume, of 161,400 shares, the short-interest ratio is presently 0.0 days.

Wall Street Analyst Weigh In

Separately, Zacks Research raised Sysmex from a "strong sell" rating to a "hold" rating in a research note on Thursday, August 14th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Sysmex currently has a consensus rating of "Hold".

Sysmex Stock Up 2.3%

Sysmex stock traded up $0.29 on Friday, hitting $13.12. 104,172 shares of the stock traded hands, compared to its average volume of 127,035. The company has a current ratio of 3.37, a quick ratio of 2.49 and a debt-to-equity ratio of 0.12. The firm has a market cap of $8.26 billion, a P/E ratio of 26.24 and a beta of 1.10. The business's fifty day simple moving average is $15.21 and its 200 day simple moving average is $16.99. Sysmex has a 1 year low of $12.50 and a 1 year high of $22.00.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.07). The firm had revenue of $717.09 million for the quarter, compared to analysts' expectations of $807.27 million. Sysmex had a net margin of 9.35% and a return on equity of 10.20%. As a group, sell-side analysts forecast that Sysmex will post 0.57 earnings per share for the current year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.